药物性肺损伤:基于临床场景与影像模式的诊断方法
药物性肺损伤(MIPI)日益常见但诊断困难。本文归纳六种常见影像模式(类结节病型、弥漫性磨玻璃影、机化性肺炎、小叶中心性磨玻璃结节、线状间隔型、纤维化型),并将其置于五个临床场景(风湿/消化科、心内科、血液科、肿瘤科、住院患者)中,结合常用药物类别进行讨论;同时对比各场景中肺病的替代病因。由于缺乏特异性诊断试验,确诊常依赖多学科共识。
要点
- 认识六种MIPI影像模式有助于将药物性肺损伤纳入鉴别诊断
- 结合临床场景(如风湿科用改善病情抗风湿药)可缩小可疑药物范围
- MIPI无特异性诊断试验,工作诊断常依赖多学科共识
核心结论
- 熟悉常用药物相关的最常见影像模式有助于将MIPI纳入获得性肺病的鉴别诊断,但缺乏特异性诊断试验常阻碍确诊,工作诊断通常依赖多学科共识。
研究设计与样本
- 本文为综述,描述六种与MIPI相关的影像模式,并在五个临床场景中讨论其发生与常用药物及药物类别,同时与各场景中肺病的替代病因进行对比。
关键影像表现/征象
- 与MIPI相关的六种影像模式包括类结节病型、弥漫性磨玻璃影、机化性肺炎、小叶中心性磨玻璃结节、线状间隔型和纤维化型。
临床应用与阅片要点
- 结合对MIPI最常见影像模式的认识与患者特定临床场景中可能暴露的药物,可辅助诊断。
- 需将MIPI与各场景中肺病的替代病因进行对比,如风湿科中的结缔组织病相关间质性肺病和心内科中的静水压性肺水肿。
局限性
- 缺乏MIPI的特异性诊断试验,常阻碍确诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Medication-induced pulmonary injury (MIPI) is a complex medical condition that has become increasingly common yet remains stubbornly difficult to diagnose. Diagnosis can be aided by combining knowledge of the most common imaging patterns caused by MIPI with awareness of which medications a patient may be exposed to in specific clinical settings. The authors describe six imaging patterns commonly associated with MIPI: sarcoidosis-like, diffuse ground-glass opacities, organizing pneumonia, centrilobular ground-glass nodules, linear-septal, and fibrotic. Subsequently, the occurrence of these patterns is discussed in the context of five different clinical scenarios and the medications and medication classes typically used in those scenarios. These scenarios and medication classes include the rheumatology or gastrointestinal clinic (disease-modifying antirheumatic agents), cardiology clinic (antiarrhythmics), hematology clinic (cytotoxic agents, tyrosine kinase inhibitors, retinoids), oncology clinic (immune modulators, tyrosine kinase inhibitors, monoclonal antibodies), and inpatient service (antibiotics, blood products). Additionally, the article draws comparisons between the appearance of MIPI and the alternative causes of lung disease typically seen in those clinical scenarios (eg, connective tissue disease-related interstitial lung disease in the rheumatology clinic and hydrostatic pulmonary edema in the cardiology clinic). Familiarity with the most common imaging patterns associated with frequently administered medications can help insert MIPI into the differential diagnosis of acquired lung disease in these scenarios. However, confident diagnosis is often thwarted by absence of specific diagnostic tests for MIPI. Instead, a working diagnosis typically relies on multidisciplinary consensus. ©RSNA, 2021.
引用
- Sridhar, Kanne, Henry, et al. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem. Radiographics. 2021. PMID: 34826256. doi:10.1148/rg.210146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。